186 related articles for article (PubMed ID: 18576443)
1. The influence of densely organized maltose shells on the biological properties of poly(propylene imine) dendrimers: new effects dependent on hydrogen bonding.
Klajnert B; Appelhans D; Komber H; Morgner N; Schwarz S; Richter S; Brutschy B; Ionov M; Tonkikh AK; Bryszewska M; Voit B
Chemistry; 2008; 14(23):7030-41. PubMed ID: 18576443
[TBL] [Abstract][Full Text] [Related]
2. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
[TBL] [Abstract][Full Text] [Related]
3. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
[TBL] [Abstract][Full Text] [Related]
4. Influence of surface functionality of poly(propylene imine) dendrimers on protease resistance and propagation of the scrapie prion protein.
Fischer M; Appelhans D; Schwarz S; Klajnert B; Bryszewska M; Voit B; Rogers M
Biomacromolecules; 2010 May; 11(5):1314-25. PubMed ID: 20405854
[TBL] [Abstract][Full Text] [Related]
5. Gd-Chelated poly(propylene imine) dendrimers with densely organized maltose shells for enhanced MR imaging applications.
Xiong Z; Wang Y; Zhu J; He Y; Qu J; Effenberg C; Xia J; Appelhans D; Shi X
Biomater Sci; 2016 Oct; 4(11):1622-1629. PubMed ID: 27722500
[TBL] [Abstract][Full Text] [Related]
6. Influence of different generations of poly(propylene imine) dendrimers on human erythrocytes.
Mishra V; Gupta U; Jain NK
Pharmazie; 2010 Dec; 65(12):891-5. PubMed ID: 21284258
[TBL] [Abstract][Full Text] [Related]
7. The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stability.
Ciolkowski M; Pałecz B; Appelhans D; Voit B; Klajnert B; Bryszewska M
Colloids Surf B Biointerfaces; 2012 Jun; 95():103-8. PubMed ID: 22410344
[TBL] [Abstract][Full Text] [Related]
8. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
[TBL] [Abstract][Full Text] [Related]
9. Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5'-triphosphates.
Szulc A; Signorelli M; Schiraldi A; Appelhans D; Voit B; Bryszewska M; Klajnert-Maculewicz B; Fessas D
Int J Pharm; 2015 Nov; 495(2):940-7. PubMed ID: 26456295
[TBL] [Abstract][Full Text] [Related]
10. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
Klementieva O; Benseny-Cases N; Gella A; Appelhans D; Voit B; Cladera J
Biomacromolecules; 2011 Nov; 12(11):3903-9. PubMed ID: 21936579
[TBL] [Abstract][Full Text] [Related]
11. Investigations on the toxicological profile of functionalized fifth-generation poly (propylene imine) dendrimer.
Agashe HB; Dutta T; Garg M; Jain NK
J Pharm Pharmacol; 2006 Nov; 58(11):1491-8. PubMed ID: 17132212
[TBL] [Abstract][Full Text] [Related]
12. Sugar-decorated dendritic nanocarriers: encapsulation and release of the octahedral rhenium cluster complex [Re6S8(OH)6]4-.
Kubeil M; Stephan H; Pietzsch HJ; Geipel G; Appelhans D; Voit B; Hoffmann J; Brutschy B; Mironov YV; Brylev KA; Fedorov VE
Chem Asian J; 2010 Dec; 5(12):2507-14. PubMed ID: 20677321
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of amyloid and prion fibril formation in the absence and presence of dense shell sugar-decorated dendrimers.
Ottaviani MF; Cangiotti M; Fiorani L; Fattori A; Wasiak T; Appelhans D; Klajnert B
Curr Med Chem; 2012; 19(34):5907-21. PubMed ID: 22834819
[TBL] [Abstract][Full Text] [Related]
14. Internalization and intracellular trafficking of poly(propylene imine) glycodendrimers with maltose shell in melanoma cells.
Filimon A; Sima LE; Appelhans D; Voit B; Negroiu G
Curr Med Chem; 2012; 19(29):4955-68. PubMed ID: 23033945
[TBL] [Abstract][Full Text] [Related]
15. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
[TBL] [Abstract][Full Text] [Related]
16. Effect of surface capping on targeting potential of folate decorated poly (propylene imine) dendrimers.
Birdhariya B; Kesharwani P; Jain NK
Drug Dev Ind Pharm; 2015; 41(8):1393-9. PubMed ID: 25163759
[TBL] [Abstract][Full Text] [Related]
17. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
[TBL] [Abstract][Full Text] [Related]
18. Sugar-Modified Poly(propylene imine) Dendrimers Stimulate the NF-κB Pathway in a Myeloid Cell Line.
Jatczak-Pawlik I; Gorzkiewicz M; Studzian M; Appelhans D; Voit B; Pulaski L; Klajnert-Maculewicz B
Pharm Res; 2017 Jan; 34(1):136-147. PubMed ID: 27766462
[TBL] [Abstract][Full Text] [Related]
19. Influence of core and maltose surface modification of PEIs on their interaction with plasma proteins-Human serum albumin and lysozyme.
Wrobel D; Marcinkowska M; Janaszewska A; Appelhans D; Voit B; Klajnert-Maculewicz B; Bryszewska M; Štofik M; Herma R; Duchnowicz P; Maly J
Colloids Surf B Biointerfaces; 2017 Apr; 152():18-28. PubMed ID: 28064094
[TBL] [Abstract][Full Text] [Related]
20. Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
Szulc A; Pulaski L; Appelhans D; Voit B; Klajnert-Maculewicz B
Int J Pharm; 2016 Nov; 513(1-2):572-583. PubMed ID: 27667754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
